Fate Therapeutics, Inc. (FATE)
NASDAQ: FATE · Real-Time Price · USD
1.060
-0.070 (-6.19%)
Aug 14, 2025, 11:45 AM - Market open

Fate Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Cash & Equivalents
41.2536.0641.8761.33133.58167.35
Upgrade
Short-Term Investments
181.58243.01273.31374.89482.33315.57
Upgrade
Cash & Short-Term Investments
222.83279.07315.18436.23615.91482.92
Upgrade
Cash Growth
-26.91%-11.46%-27.75%-29.17%27.54%118.09%
Upgrade
Accounts Receivable
1.43.541.8338.488.685.52
Upgrade
Other Receivables
22.10.90.81.11.5
Upgrade
Receivables
3.45.642.7339.289.787.02
Upgrade
Prepaid Expenses
4.177.213.6426.577.734.39
Upgrade
Total Current Assets
230.4291.91331.54502.07633.41494.32
Upgrade
Property, Plant & Equipment
104.91110.89158.51176.09162.2599.39
Upgrade
Long-Term Investments
26.127.660.984.94100.66-
Upgrade
Long-Term Deferred Charges
---7.29.8713.51
Upgrade
Other Long-Term Assets
10.2310.2415.1915.2615.2615.24
Upgrade
Total Assets
371.63440.69506.22705.56921.46622.46
Upgrade
Accounts Payable
4.049.374.728.278.616.28
Upgrade
Accrued Expenses
18.1821.3527.5153.9342.4115.56
Upgrade
Current Portion of Leases
5.667.426.185.635.583.36
Upgrade
Current Unearned Revenue
-0.390.6942.2321.4821.14
Upgrade
Other Current Liabilities
0.8--43.239.22
Upgrade
Total Current Liabilities
28.6738.5239.09114.0581.2885.56
Upgrade
Long-Term Leases
75.6877.8597.36103.71109.2493.94
Upgrade
Long-Term Unearned Revenue
----27.1246.02
Upgrade
Other Long-Term Liabilities
5.925.61.353.8624.9712.48
Upgrade
Total Liabilities
110.27121.97137.8221.62242.62238.01
Upgrade
Common Stock
0.120.110.10.10.10.09
Upgrade
Additional Paid-In Capital
1,7311,7161,5801,5361,449941.22
Upgrade
Retained Earnings
-1,470-1,398-1,212-1,051-769.08-556.93
Upgrade
Comprehensive Income & Other
0.060.270.02-1.85-0.760.07
Upgrade
Total Common Equity
261.36318.72368.41483.94678.84384.44
Upgrade
Shareholders' Equity
261.36318.73368.42483.94678.84384.45
Upgrade
Total Liabilities & Equity
371.63440.69506.22705.56921.46622.46
Upgrade
Total Debt
81.3385.27103.54109.34114.8297.3
Upgrade
Net Cash (Debt)
141.5193.8211.64326.89501.09385.62
Upgrade
Net Cash Growth
-30.75%-8.43%-35.26%-34.77%29.95%98.26%
Upgrade
Net Cash Per Share
1.201.702.153.385.294.68
Upgrade
Filing Date Shares Outstanding
115.33114.699.2498.1696.4393.78
Upgrade
Total Common Shares Outstanding
114.66113.9398.6397.2995.7387.72
Upgrade
Working Capital
201.72253.39292.45388.02552.13408.76
Upgrade
Book Value Per Share
2.282.803.744.977.094.38
Upgrade
Tangible Book Value
261.36318.72368.41483.94678.84384.44
Upgrade
Tangible Book Value Per Share
2.282.803.744.977.094.38
Upgrade
Machinery
-38.8583.2981.553.6322.25
Upgrade
Construction In Progress
-----18.19
Upgrade
Leasehold Improvements
-59.4959.0456.7852.952.7
Upgrade
Updated Aug 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q